Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
Anouk E. Hiensch(Utrecht University), Anne M. May(Utrecht University), Onno Kranenburg(Utrecht University), Jeroen A. L. Jeneson(University Medical Center Groningen), Kate A. Bolam(Karolinska Institutet), Yvonne Wengström(Karolinska Institutet), Helene Rundqvist(Karolinska University Hospital), Sara Mijwel(Karolinska Institutet), Elsken van der Wall(University Medical Center Utrecht), Alwin D. R. Huitema(The Netherlands Cancer Institute)
Cited by 122
Related Papers
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
|JNCI Journal of the National Cancer Institute|2001|593
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
|Cancer|2003|499
Clinical Pharmacokinetics of Cyclophosphamide
|Clinical Pharmacokinetics|2005|451
Up‐regulation of gene expression by hypoxia is mediated predominantly by hypoxia‐inducible factor 1 (HIF‐1)
|The Journal of Pathology|2005|449